Allusion

SettleMint is a developer of a user-friendly blockchain platform that allows web2 engineers to build, deploy, and integrate applications on web3 infrastructure. Its low-code platform encompasses the entire web3 application development lifecycle, featuring node hosting as a service that enables quick deployment across various protocols and cloud regions. The platform offers a library of customizable smart contract templates for over 50 use cases, efficient data querying through full Graph QL integration, and decentralized data storage via IPFS nodes. Additionally, SettleMint provides an automated user interface builder and scalable resources for deployed services. The company, SOC2 certified and designed for enterprise use, aims to simplify web3 development by reducing complexity and risk. With a presence in Europe, the Middle East, India, and Asia-Pacific, SettleMint operates offices in several major cities, including Belgium, Dubai, Delhi, Singapore, and Tokyo.

CellRev is a biotechnology company that specializes in advancing cell manufacturing processes through innovative bioprocessing technology. The company focuses on enabling the transition from traditional batch processing to continuous processing for adherent cells, which enhances yield and reduces both operating costs and capital expenditure. By addressing critical challenges such as aggregation, clumping, and cell detachment, CellRev offers unique solutions for developers in the fields of cultured meat, cell therapy, and biologics. Its proprietary cell detachment process, combined with a specially designed bioprocess, positions CellRev as a leader in improving the efficiency of manufacturing processes for cell-based vaccines, therapies, and drugs. This disruptive approach aims to eliminate the need for serum in production, thereby streamlining operations for clients in the biomanufacturing landscape.